Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,095 public trials 2,042 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

NCT02808442

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • Hôpital Robert-Debré Paris, France
View Trial Details
Completed

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

NCT01353625

Conditions
Astrocytoma, Blood Protein Disorders, Carcinoma, +52 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • University of California, San Francisco Comprehensive Cancer Center and Cancer Research Institiute San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 17 locations
View Trial Details
Completed

Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma

NCT01381692

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Completed

Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis

NCT02888080

Conditions
Autoimmune Diseases, Granuloma, Hemic and Lymphatic Diseases, +14 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Albany, New York, United States
  • Novartis Investigative Site Cleveland, Ohio, United States
  • Novartis Investigative Site Essen, Germany
View Trial Details
Completed

Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia

NCT02746952

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Hôpital Saint-Louis Paris, France
View Trial Details

Related conditions